INSERM (Institut National de la Santé et de la Recherche Médicale);EDELRIS;Centre National de la Recherche Scientifique (CNRS);Université Claude Bernard - Lyon 1;ENS - Ecole Normale Supérieure de Lyon
发明人:
ANDRE, Patrice,LOTTEAU, Vincent,RADREAU, Pauline,GILARDONE, Marine,PATIN, Amaury,ROCHE, Didier,CRAVO, Daniel,HALLAKOU-BOZEC, Sophie
申请号：
AU2018236856
公开号：
AU2018236856A1
申请日:
2018.09.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018236856A120181018.pdf#####METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Abstract The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus infection. In particular, the present invention relates to a method for treating a chronic hepatitis B virus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a farnesoid X receptor (FXR) agonist, as well as the use of farnesoid X receptor (FXR) agonist for the manufacture of a medicament for treating a chronic hepatitis B virus infection in a subject in need thereof.
